U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 761216
Company: COHERUS BIOSCIENCES INC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
YUSIMRY ADALIMUMAB-AQVH 40MG INJECTABLE;INJECTION Prescription None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/17/2021 ORIG-1 Approval N/A Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761216s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/761216Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/761216Orig1s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/13/2023 SUPPL-4 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761216Orig1s004ltr.pdf
03/31/2023 SUPPL-3 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761216Orig1s003ltr.pdf
02/27/2023 SUPPL-1 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761216Orig1s001ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
09/13/2023 SUPPL-4 Bioequivalence Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s004lbl.pdf
03/31/2023 SUPPL-3 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s003lbl.pdf
02/27/2023 SUPPL-1 Efficacy-Labeling Change With Clinical Data Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s001lbl.pdf
12/17/2021 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761216s000lbl.pdf
Back to Top